Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00030797
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Irinotecan 70 mg/m2
DRUG:
Irinotecan 240 mg/m2
Sponsor
Swiss Cancer Institute